tiprankstipranks
Advertisement
Advertisement
Orasis Pharmaceuticals Emphasizes Presbyopia Drop Category and Prescriber Engagement
PremiumPrivate CompaniesOrasis Pharmaceuticals Emphasizes Presbyopia Drop Category and Prescriber Engagement
25d ago
Orasis Pharmaceuticals – Weekly Recap
Premium
Private Companies
Orasis Pharmaceuticals – Weekly Recap
1M ago
Orasis Highlights First-Year Qlosi Uptake and Safety Indicators
Premium
Private Companies
Orasis Highlights First-Year Qlosi Uptake and Safety Indicators
1M ago
Orasis Pharmaceuticals Builds Presbyopia, Pilocarpine Profile Ahead of SECO 2026
PremiumPrivate CompaniesOrasis Pharmaceuticals Builds Presbyopia, Pilocarpine Profile Ahead of SECO 2026
3M ago
Orasis Highlights Presbyopia Drop Education Effort at SECO Conference
Premium
Private Companies
Orasis Highlights Presbyopia Drop Education Effort at SECO Conference
3M ago
Orasis Pharmaceuticals Targets Prescriber Engagement Around Low-Concentration Pilocarpine at SECO 2026
Premium
Private Companies
Orasis Pharmaceuticals Targets Prescriber Engagement Around Low-Concentration Pilocarpine at SECO 2026
3M ago
Orasis Pharmaceuticals – Weekly Recap
PremiumPrivate CompaniesOrasis Pharmaceuticals – Weekly Recap
3M ago
Patient-Centric Marketing Underscores Orasis Focus on Presbyopia Eye-Drop Adoption
Premium
Private Companies
Patient-Centric Marketing Underscores Orasis Focus on Presbyopia Eye-Drop Adoption
3M ago
Patient Experience Spotlight Highlights Commercial Focus for Orasis Presbyopia Drop
Premium
Private Companies
Patient Experience Spotlight Highlights Commercial Focus for Orasis Presbyopia Drop
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100